Omega-3 Clinical Study Database to catalog all EPA, DHA human trials – podcast
The database will be searchable by demographics, dosage, intervention and outcome, explains Ellen Schutt, executive director, GOED.
The Omega-3 Clinical Study Database, now in phase 2 data extraction, will one day be a searchable database of human clinical trials that examined the effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), or the combination of those two long-chain omega-3s.
GOED (The Global Organization for EPA and DHA Omega-3s) started this endeavor two years ago, as Ellen Schutt, executive director, explains in this Healthy Insider Podcast, and has narrowed down 35,000 potential studies into 4,000 specifically focused on EPA/DHA that need to be categorized for demographics, dosage, intervention and outcome.
With Sandy Almendarez, content director, INSIDER, Schutt talks about the Omega-3 Clinical Study Database, including:
Who will benefit from the database and who will have access
How this database will be different from other research archives, such as PubMed.
How attendees of the 2020 GOED Exchange will see sneak peek of the database.
Learn more about the Omega-3 Clinical Study Database from Aldo Bernasconi, Ph.D., director of information and research, GOED, at the GOED Exchange, Feb. 4 to 6, 2020 in Barcelona, Spain.
About the Author
You May Also Like